Shares of Evotec SE (ETR:EVT – Get Free Report) were up 0.3% during mid-day trading on Tuesday . The company traded as high as €10.50 ($11.05) and last traded at €10.50 ($11.05). Approximately 2,505,337 shares traded hands during trading, an increase of 84% from the average daily volume of 1,360,000 shares. The stock had previously closed at €10.47 ($11.02).
Evotec Price Performance
The firm has a 50 day moving average price of €6.77 and a 200 day moving average price of €7.73. The stock has a market capitalization of $1.76 billion, a PE ratio of -10.32, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The company has a current ratio of 1.83, a quick ratio of 2.97 and a debt-to-equity ratio of 46.81.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Recommended Stories
- Five stocks we like better than Evotec
- 3 Tickers Leading a Meme Stock Revival
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- About the Markup Calculator
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
